ASCO's Sunday plenary session will open with results of a 2,109-person global prostate cancer study that showed adding ...
Thousands of men with advanced prostate cancer could soon live longer thanks to a treatment which cuts the risk of the ...
By Bhanvi Satija May 31 (Reuters) - Novartis said on Sunday that early data from its experimental actinium-based drug showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results